Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Molecular Cell
|
February 13, 2025
RIOK3 mediates the degradation of 40S ribosomes
Zixuan Huang, Frances F Diehl, Mengjiao Wang, et al.
Annals of Hematology
|
March 7, 2006
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma
Carl R Willis, Amy Goodrich, Kathy Park, et al.
Leukemia Research
|
October 11, 2012
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
Tod A Morris, Carlos M DeCastro, Louis F Diehl, et al.
Nature Cell Biology
|
August 4, 2022
Nucleotide imbalance decouples cell growth from cell proliferation
Frances F Diehl, Teemu P Miettinen, Ryan Elbashir, et al.
Blood
|
July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
I W Flinn, J C Byrd, C Morrison, et al.
Blood
|
November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry
|
April 20, 2000
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle
T Mirzadegan, F Diehl, B Ebi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2004
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma
Yvette L Kasamon, Richard J Jones, Louis F Diehl, et al.
Cancer Investigation
|
February 15, 2013
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma
Lauren A Held, David Rizzieri, Gwynn D Long, et al.
Nature Cell Biology
|
June 27, 2018
Aspartate is an endogenous metabolic limitation for tumour growth
Lucas B Sullivan, Alba Luengo, Laura V Danai, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Molecular Cell
|
February 13, 2025
RIOK3 mediates the degradation of 40S ribosomes
Zixuan Huang, Frances F Diehl, Mengjiao Wang, et al.
Annals of Hematology
|
March 7, 2006
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma
Carl R Willis, Amy Goodrich, Kathy Park, et al.
Leukemia Research
|
October 11, 2012
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
Tod A Morris, Carlos M DeCastro, Louis F Diehl, et al.
Nature Cell Biology
|
August 4, 2022
Nucleotide imbalance decouples cell growth from cell proliferation
Frances F Diehl, Teemu P Miettinen, Ryan Elbashir, et al.
Blood
|
July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
I W Flinn, J C Byrd, C Morrison, et al.
Blood
|
November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry
|
April 20, 2000
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle
T Mirzadegan, F Diehl, B Ebi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2004
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma
Yvette L Kasamon, Richard J Jones, Louis F Diehl, et al.
Cancer Investigation
|
February 15, 2013
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma
Lauren A Held, David Rizzieri, Gwynn D Long, et al.
Nature Cell Biology
|
June 27, 2018
Aspartate is an endogenous metabolic limitation for tumour growth
Lucas B Sullivan, Alba Luengo, Laura V Danai, et al.
Page
of 13